| SC 13G | 2018-06-27 | Famous Sino Ltd | Sorrento Therapeutics, Inc. | 6,831,955 | 7.0% | EDGAR |
| SC 13G/A | 2018-06-22 | China In Shine Investment Ltd | Sorrento Therapeutics, Inc. | 7,931,955 | 6.7% | EDGAR |
| SC 13G/A | 2018-06-22 | Asia Pacific MedTech (BVI) Ltd | Sorrento Therapeutics, Inc. | 10,304,975 | 8.8% | EDGAR |
| SC 13G | 2018-06-22 | China In Shine Investment Ltd | Sorrento Therapeutics, Inc. | 4,407,713 | 5.0% | EDGAR |
| SC 13G | 2018-06-22 | Hongguo International Holdings Ltd | Sorrento Therapeutics, Inc. | 4,407,713 | 5.0% | EDGAR |
| SC 13G | 2018-06-22 | Top Path Asia Ltd | Sorrento Therapeutics, Inc. | 4,407,713 | 5.0% | EDGAR |
| SC 13G | 2018-06-22 | China In Shine Investment Ltd | Sorrento Therapeutics, Inc. | 6,831,955 | 7.0% | EDGAR |
| SC 13G | 2018-06-22 | Hongguo International Holdings Ltd | Sorrento Therapeutics, Inc. | 6,831,955 | 7.0% | EDGAR |
| SC 13G | 2018-06-22 | Top Path Asia Ltd | Sorrento Therapeutics, Inc. | 6,831,955 | 7.0% | EDGAR |
| SC 13G/A | 2018-05-22 | Xianjian Advanced Technology Ltd | Sorrento Therapeutics, Inc. | 7,342,553 | 7.9% | EDGAR |
| SC 13G/A | 2018-02-13 | Wildcat Capital Management, LLC | Sorrento Therapeutics, Inc. | 1,738,232 | 2.2% | EDGAR |
| SC 13D/A | 2018-02-08 | Ally Bridge Group Capital Partners II, L.P. | Sorrento Therapeutics, Inc. | 1,310,588 | 1.6% | EDGAR |
| SC 13G | 2018-01-26 | Ji Henry | Sorrento Therapeutics, Inc. | 4,923,638 | 5.9% | EDGAR |
| SC 13D | 2017-07-10 | Ally Bridge Group Capital Partners II, L.P. | Sorrento Therapeutics, Inc. | 1,397,853 | 1.8% | EDGAR |
| SC 13G/A | 2017-05-15 | Xianjian Advanced Technology Ltd | Sorrento Therapeutics, Inc. | 5,020,516 | 6.7% | EDGAR |
| SC 13G | 2017-05-15 | Xianjian Advanced Technology Ltd | Sorrento Therapeutics, Inc. | 3,341,118 | 4.4% | EDGAR |
| SC 13G | 2017-05-01 | Asia Pacific MedTech (BVI) Ltd | Sorrento Therapeutics, Inc. | 9,563,239 | 12.8% | EDGAR |
| SC 13G/A | 2017-02-14 | Cormorant Asset Management, LLC | Sorrento Therapeutics, Inc. | 1,588,861 | - | EDGAR |
| SC 13G | 2017-02-14 | Wildcat Capital Management, LLC | Sorrento Therapeutics, Inc. | 2,676,193 | 5.3% | EDGAR |
| SC 13G/A | 2017-02-13 | Sorrento Therapeutics, Inc. | NantKwest, Inc. | 0 | 0.0% | EDGAR |